Evidence map›Paper›PMID 20219889›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2010

Research resource: expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene.

Charles E Foulds, Anna Tsimelzon, Weiwen Long, Andrew Le, Sophia Y Tsai, Ming-Jer Tsai, Bert W O'Malley

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Progress in understanding the relationship between long noncoding RNA and endometriosis.European journal of obstetrics & gynecology and reproductive biology: X · 2020
    Review
  11. Article
  12. AAV9-Molecular therapy. Methods & clinical development · 2019
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Charles E FouldsDepartment of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
Anna Tsimelzon
Weiwen Long
Andrew Le
Sophia Y Tsai
Ming-Jer Tsai
Bert W O'Malley
Baylor College of Medicine · US

Funding

SEX HORMONE RECEPTOR COMPONENTS AND THE CELL GENOMER01HD007857 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI DAVID M LONARD, JOHN P LYDON · 1985 to 2026
$14.6M
MECHANISMS OF ACTION OF COUP TRANSCRIPTION FACTORSR01DK045641 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI TSAI, MING-JER · 1992 to 2014
$2.2M
NICHD NIH HHS 5 R01 HD07857NICHD NIH HHS HD08818NICHD NIH HHS R01 HD007857NIDDK NIH HHS R01 DK045641
6 · The paper itself

Abstract

The human steroid receptor RNA activator (SRA) gene encodes both noncoding RNAs (ncRNAs) and protein-generating isoforms. In reporter assays, SRA ncRNA enhances nuclear receptor and myogenic differentiation 1 (MyoD)-mediated transcription but also participates in specific corepressor complexes, serving as a distinct scaffold. That SRA RNA levels might affect some biological functions, such as proliferation, apoptosis, steroidogenesis, and myogenesis, has been reported. However, the breadth of endogenous target genes that might be regulated by SRA RNAs remains largely unknown. To address this, we depleted SRA RNA in two human cancer cell lines with small interfering RNAs and then assayed for changes in gene expression by microarray analyses. The majority of significantly changed genes were reduced upon SRA knockdown, implicating SRA RNAs as endogenous coactivators. Unexpectedly, only a small subset of direct estrogen receptor-alpha target genes was affected in estradiol-treated MCF-7 cells. Eight bona fide SRA downstream target genes were identified (SLC2A3, SLC2A12, CCL20, TGFB2, DIO2, TMEM65, TBL1X, and TMPRSS2), representing entirely novel SRA targets, except for TMPRSS2. These data suggest unanticipated roles for SRA in glucose uptake, cellular signaling, T(3) hormone generation, and invasion/metastasis. SRA depletion in MDA-MB-231 cells reduced invasiveness and expression of some genes critical for this process. Consistent with the knockdown data, overexpressed SRA ncRNA coactivates certain target promoters and may enhance the activity of some coregulatory proteins. This study is a valuable resource because it represents the first genome-wide analysis of a mammalian RNA coregulator.

Indexed as

Cell Line, TumorGene Expression ProfilingGene Expression RegulationGlucose Transporter Type 3HeLa CellsHumansIodide PeroxidaseIodothyronine Deiodinase Type IIOligonucleotide Array Sequence AnalysisReverse Transcriptase Polymerase Chain ReactionRNA, Long NoncodingRNA, Small InterferingRNA, UntranslatedSignal TransductionGlucose Transporter Type 3Iodide PeroxidaseIodothyronine Deiodinase Type IIRNA, Long NoncodingRNA, Small InterferingRNA, Untranslatedsteroid receptor RNA activator

Identifiers

PMID20219889
PMCPMC2870939
OpenAlexW2128940728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.